Nevertheless, Villar et al., showed evidence that CD5+ (innate) B cells are the source of persistent anti-lipid IgM antibodies that constitute part of the oligoclonal IgM bands in the CSF [200]—a characteristic biomarker seen in the CSF of MS patients [117,200]. This evidence concerns the gene CD5 and myeloid sarcoma.